1. Home
  2. News and Media
  3. Press Releases

Press Releases

  • CAP Files Legal Brief Supporting Challenge to Correct Scheme for Setting Medicare Fees for Clinical Laboratory Tests

    The CAP filed an amicus brief in support of the American Clinical Laboratory Association’s appeal to overturn a decision dismissing its lawsuit to correct the Department of Health and Human Services’ execution of reforms to Medicare’s clinical laboratory fee schedule. 

  • CAP Program Empowers Pathologists to Lead Optimal Test Ordering

    With the newest module in the CAP’s Test Ordering Program, “Biomarkers in Colorectal Cancer,” CAP members can handily help other doctors navigate testing and ensure the proper tests are ordered for each patient. 

  • CDC awards the College of American Pathologists five-year cancer reporting grant

    The Centers for Disease Control and Prevention (CDC) awarded the College of American Pathologists (CAP) a five-year, $300,000/year collaborative grant to further address standardization and support for diagnostic cancer and biomarker electronic reporting.

  • New Illustrated Mycology Guide Aids Accurate Diagnostics

    Available now from CAP Press, the Color Atlas of Mycology: An Illustrated Field Guide Based on Proficiency Testing, by Gordon L. Love, MD, FCAP, and Julie A. Ribes, MD, FCAP, is an up-to-date resource that assists pathologists and medical technologists in the laboratory identification of fungi using the most recent taxonomic classifications. The text includes more than 15 years of proficiency testing data to highlight diagnostic clusters of incorrect identifications and address conceptual classification issues. 

  • URAC, NCQA Urged to Adopt Health Plan Network Adequacy Standards

    Hospital-based physicians urged quality improvement organizations to protect patients from high medical bills by setting oversight standards to ensure health plans maintain adequate numbers of in-network providers at hospitals.

  • Evidence-based lymphoma pathology guideline open for comment

    CAP, ASCP and ASH open draft of interdisciplinary lymphoma diagnostic guideline for public comment

  • Powerful Search Tool Now Accesses CAP CME

    CAP portfolio of continuing medical education is now available through CME Finder, a resource of the Accreditation Council for Continuing Medical Education.

  • CAP Statement on US District Court Opinion on Lawsuit Against HHS

    College of American Pathologists (CAP) President R. Bruce Williams, MD, FCAP issued the following statement after the U.S. District Court for the District of Columbia in American Clinical Laboratory Association (ACLA) v Azar

  • Pathologists Confront the Opioid Crisis

    A CAP position statement creating solutions for combating the opioid crisis by performing the right laboratory tests and ensuring that patients have access to safer and more effective chronic pain treatment while reducing the risk of opioid use disorder, overdose and death.

  • A Statement by CAP President R. Bruce Williams on the Local Coverage Determination Clarification Act

    College of American Pathologists (CAP) President R. Bruce Williams, MD, FCAP issued the following statement on the House Ways and Means Committee markup of the Local Coverage Determination Clarification Act (H.R. 3635).

  • 2018 CAP Accreditation Checklists Detail Medical Laboratories' Blueprint For Compliance And Best Practice

    Published today, The College of American Pathologists (CAP) published the 2018 edition of its accreditation program checklists on August 22, 2018, providing medical laboratories a blueprint for maintaining compliance with the Centers for Medicare and Medicaid Services (CMS) regulations.

  • Updated Guideline For HER2 Testing In Breast Cancer Aids Physicians, Patients

    Published today, a Focused Update to the American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) guideline for human epidermal growth factor receptor 2 (HER2) testing in breast cancer brings new levels of clarity that will benefit patients and clinical teams alike.

  • Guideline To Improve Collection, Handling Of Thoracic Specimens Opens For Comment

    For patients battling lung disease, advances in minimally invasive techniques allow clinicians to now perform multiple ancillary tests on small biopsy specimens. To ensure optimal diagnostic testing and management in these cases, the College of American Pathologists (CAP) is developing an evidence-based clinical guideline.

  • The CAP's Annual Report Highlights Progress in Diagnostic Medicine to Improve Patient Health

    People are healthier today because of advances in pathology and laboratory medicine. Whether you have a tissue sample examined in a biopsy or get routine blood work, you can trust the expertise behind your results, according to the College of American Pathologists (CAP), which released its 2017 ANNUAL REPORT

  • A Statement by College of American Pathologists (CAP) President R. Bruce Williams, MD, FCAP on Final Next-Generation Sequencing Medicare Coverage Proposal

    “The CAP applauds the Centers for Medicare & Medicaid Services (CMS) for revising its final national coverage determination (NCD) policy for next-generation sequencing (NGS) to address some of the concerns raised by the CAP and other stakeholders. The implementation of the draft NCD criteria for NGS would have had profound adverse and immediate consequences for Medicare beneficiary access to therapies, and negatively impact the treating physician's ability to order medically necessary tests for patients. While the final NCD nationally covers only approved or U.S. Food and Drug Administration (FDA) cleared tests using NGS, the final determination leaves the local Medicare Administrative Contractor with the discretion to cover all other tests as long as specific patient criteria are met. The expanded criteria include recurrent, relapsed, refractory, metastatic, and advanced stages III or stages IV of cancer.” – CAP President R. Bruce Williams, MD, FCAP

  • Liquid Biopsy Tests in People with Cancer: An Expert Review More Evidence Needed to Establish Effective and Appropriate Use in the Clinic

    Use of tests that assess genomic variants in circulating tumor DNA (ctDNA) is on the rise. A new joint review from the American Society of Clinical Oncology (ASCO) and the College of American Pathologists (CAP) provides an assessment of evidence on ctDNA tests in oncology. It also lays out a framework for future research and clinical practice guidelines to help better inform clinical practice.

  • CAP Files Amicus Brief In Support Of ACLA Motion For Summary Judgement In PAMA Lawsuit

    The College of American Pathologists (CAP) filed an amicus curiae brief in support of a motion by the American Clinical Laboratory Association (ACLA) for summary judgement to set aside how the Department of Health and Human Services (HHS) implemented market-based reforms to clinical laboratory fees mandated by the Protecting Access to Medicare Act (PAMA) of 2014. The CAP has strongly supported ACLA’s lawsuit against the HHS and efforts to correct the administration’s execution of PAMA’s clinical laboratory payment reforms.

  • CMS Grants 2018 QCDR Status To The Pathologists Quality Registry

    The PATHOLOGISTS QUALITY REGISTRY has been approved as a 2018 Qualified Clinical Data Registry (QCDR) by the Centers for Medicare & Medicaid Services (CMS) for the second consecutive year, solidifying the tool as an instrumental component for pathologists in fulfilling reporting requirements under Medicare's Quality Payment Program (QPP) Merit-Based Incentive Payment System (MIPS). Developed by pathologists for pathologists, the Pathologists Quality Registry offers additional pathology-specific quality measures and attestation for improvement activities, helping pathologists demonstrate quality care while maximizing Medicare payment bonus potential.

  • New Color Atlas of Hematology Second Edition Now Available

    The College of American Pathologists (CAP) has published the second edition of the leading reference text for peripheral blood pathology, the Color Atlas of Hematology. Updated, expanded content builds on the original edition, but adds mixed-media content across more than 400 highly visual pages, many with images linked digitally to virtual peripheral blood smears, allowing the reader to view them as they would appear under a microscope. Other links take the user to educational videos from the authors.

  • Guideline For Molecular Testing In Lung Cancer Revised, Updated

    Rapid advancements in the molecular diagnostic testing of lung cancer have led to new treatments and greater hope for patients battling lung cancer, the most common cause of cancer death worldwide.

  1. 1
  2. 2
  3. 3
  4. 4
  5. Right Arrow
Viewing 1-20 of 64